Literature DB >> 29528384

Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension.

Matthieu Glorion1,2, Olaf Mercier1,2, Delphine Mitilian1,2, Alexandra De Lemos2, Lilia Lamrani2, Séverine Feuillet1, Pauline Pradere1, Jérôme Le Pavec1,2, Daniel Lehouerou3, François Stephan4, Laurent Savale2,5, Dominique Fabre1,2, Sacha Mussot1,2, Elie Fadel1,2.   

Abstract

OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) has become the standard of cardiopulmonary support during a sequential double lung transplant for pulmonary hypertension. Whether central or peripheral cannulation is the best strategy for these patients remains unknown. Our goal was to determine which is the best strategy by comparing 2 populations of patients.
METHODS: We performed a single-centre retrospective study based on an institutional prospective lung transplant database.
RESULTS: Between January 2011 and November 2016, 103 patients underwent double lung transplant for pulmonary hypertension. We compared 54 patients who had central ECMO (cECMO group) to 49 patients who had peripheral ECMO (pECMO group). The pECMO group had significantly more bridged patients who received emergency transplants (31% vs 6%, P = 0.001). The incidence of Grade 3 primary graft dysfunction requiring ECMO (14% vs 11%, P = not significant) and of in-hospital mortality (11% vs 14%, P = not significant) was similar between the groups. Groin infections (16% vs 4%, P = 0.031), deep vein thrombosis (27% vs 11%, P = 0.044) and lower limb ischaemia (12% vs 2%, P = 0.031) occurred significantly more often in the pECMO group. The number of chest reopenings for bleeding or infection was similar between the groups. The 3-month, 1-year and 5-year survival rates did not differ between the groups (P = 0.94).
CONCLUSIONS: Central or peripheral ECMO produced similar results during double lung transplant for pulmonary hypertension in terms of in-hospital deaths and long-term survival rates. Central ECMO provided satisfactory results without major bleeding provided the patient was weaned from ECMO at the end of the procedure. Despite the rate of groin and lower limb complications, peripheral cannulation remained the preferred solution to bridge the patient to transplant or for postoperative support.

Entities:  

Mesh:

Year:  2018        PMID: 29528384     DOI: 10.1093/ejcts/ezy089

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Extracorporeal support, during and after lung transplantation: the history of an idea.

Authors:  Fabio Ius; Igor Tudorache; Gregor Warnecke
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.

Authors:  Marius M Hoeper; Raymond L Benza; Paul Corris; Marc de Perrot; Elie Fadel; Anne M Keogh; Christian Kühn; Laurent Savale; Walter Klepetko
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

3.  Central and Peripheral Cannulation for Cardiopulmonary Bypass in Fetal Sheep: A Comparative Study.

Authors:  Yun Teng; Miao Tian; Bingxin Huang; Wentao Wu; Qiuping Jiang; Xiaokang Luo; Wei Pan; Jian Zhuang; Chengbin Zhou; Jimei Chen
Journal:  Front Cardiovasc Med       Date:  2021-12-13

Review 4.  Intraoperative support during lung transplantation.

Authors:  Pedro Reck Dos Santos; Jonathan D'Cunha
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

Review 5.  Lung transplantation for pulmonary hypertension.

Authors:  Ann Hwalek; Justin P Rosenheck; Bryan A Whitson
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

6.  Axillary artery cannulation for veno-arterial extracorporeal membrane oxygenation support in cardiogenic shock.

Authors:  Suguru Ohira; Ramin Malekan; Joshua B Goldberg; Steven L Lansman; David Spielvogel; Masashi Kai
Journal:  JTCVS Tech       Date:  2020-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.